Table 6 Biomarkers significant for feature F3 in the treatment arm, ranked by effect size
From: Case-control Indian buffet process identifies biomarkers of response to Codrituzumab
Continuous Variables | Effect Size | p-value |
|---|---|---|
CD56dimCD16bright | 1.36 | 1.76e-09 |
NK | 1.33 | 9.51e-11 |
CD56-CD16+ | 0.66 | 1.26e-06 |
DP | 0.59 | 2.14e-04 |
CD56dimCD16- | 0.44 | 4.39e-06 |
CD8 NK | 0.39 | 9.50e-08 |
DN | 0.30 | 3.58e-05 |
CD16 | 0.25 | 3.36e-10 |
NKP46 | 0.25 | 3.29e-10 |
B | 0.21 | 2.29e-04 |
CD8 | 0.21 | 2.67e-09 |
CD45 | 0.15 | 3.75e-11 |
CD3 | 0.14 | 1.00e-08 |
CD4 | 0.14 | 1.48e-06 |